Published: July 28, 2026
In a landmark step for end-of-life healthcare administration in North India, the state of Haryana has officially begun implementing procedural directives to govern the withdrawal and withholding of life-sustaining treatment for terminally ill patients.
Reported on July 26, 2026, the state health department instructed district civil surgeons—starting with major healthcare hubs like Gurgaon—to enforce a standardized, legally binding framework across all public facilities and private hospitals registered under the Clinical Establishments Act. The directive requires institutions to establish mandatory two-tier medical boards and engage local judicial magistrates to ensure that decisions surrounding life support align strictly with India’s constitutional guarantees on bodily autonomy.
The move brings Haryana into direct alignment with the Supreme Court of India’s jurisprudence on the “right to die with dignity” under Article 21 of the Constitution, operationalising guidelines formulated by the Union Ministry of Health and Family Welfare (MoHFW).
What the New Protocol Changes
For decades, clinicians and families in intensive care units (ICUs) across India faced deep uncertainty when medical interventions ceased to offer therapeutic benefit. Without a clear regulatory pathway, physicians often hesitated to withhold or withdraw life support due to fears of criminal liability or legal scrutiny, leading to prolonged medical futility and emotional distress.
Under the new directives rollout, hospitals must follow a rigid, dual-tier evaluation system before any life-sustaining treatment can be withdrawn or withheld:
-
Primary Medical Board: Once a treating clinician determines that further interventions will not alter the clinical outcome of a terminally ill patient, the hospital must constitute a Primary Medical Board. This body consists of the treating physician and two subject specialists with a minimum of five years of experience.
-
Secondary Medical Board: If the Primary Board recommends the withdrawal or withholding of treatment, the decision is referred to an independent Secondary Medical Board. Nominated by the district’s Chief Medical Officer (CMO) or Civil Surgeon, this board comprises one government medical officer and two external specialists who re-examine the medical evidence.
-
Judicial Communication: Upon concurrence between both medical boards, the formal determination must be submitted to the jurisdictional Judicial Magistrate First Class (JMFC) before any operational steps are taken.
+-----------------------------------------------------------------------------------+
| END-OF-LIFE DECISION-MAKING FLOW |
+-----------------------------------------------------------------------------------+
| 1. Primary Assessment |
| - Treating physician determines treatment is medically futile |
| - Validates patient's Advance Directive (Living Will) OR consults family |
+-----------------------------------------------------------------------------------+
│
▼
+-----------------------------------------------------------------------------------+
| 2. Primary Medical Board Evaluation |
| - Treating physician + 2 hospital specialists review case |
| - Formulates official recommendation on life-support status |
+-----------------------------------------------------------------------------------+
│
▼
+-----------------------------------------------------------------------------------+
| 3. Secondary Medical Board Verification |
| - CMO-nominated doctor + 2 independent external specialists |
| - Conducts secondary clinical audit and re-evaluates evidence |
+-----------------------------------------------------------------------------------+
│
▼
+-----------------------------------------------------------------------------------+
| 4. Judicial Oversight & Implementation |
| - Both boards concur on medical futility |
| - Formal record submitted to Judicial Magistrate First Class (JMFC) |
| - Palliative care prioritized; life-sustaining treatment withdrawn/withheld |
+-----------------------------------------------------------------------------------+
The health ministry defines life-sustaining treatment broadly to encompass mechanical ventilation, vasopressors, renal replacement therapy (dialysis), surgical procedures, blood transfusions, total parenteral nutrition, and Extracorporeal Membrane Oxygenation (ECMO). Under the protocol, withdrawal refers to the planned cessation of an existing life-sustaining intervention, whereas withholding denotes the decision not to initiate a new intervention when it offers no therapeutic benefit.
Legal and Historical Context
India’s modern end-of-life care framework rests on landmark legal precedents. In the historic 2018 judgment Common Cause v. Union of India, the Supreme Court recognized that the fundamental Right to Life under Article 21 encompasses the right to live with dignity until death, thereby legalizing passive euthanasia and Advance Medical Directives (living wills).
However, procedural hurdles in the initial 2018 ruling—such as requiring local collector approval—rendered the process largely unworkable in acute clinical environments. In January 2023, the Supreme Court issued a simplified modification, replacing burdensome administrative steps with hospital-based primary and secondary medical review boards and streamlined judicial notice protocols.
The guidelines also affirm that a decision-capable adult patient retains the absolute ethical and legal right to refuse medical treatment, even if that refusal leads to death. For patients who have lost decision-making capacity (e.g., those in deep comas or advanced vegetative states), the process relies on their pre-recorded Living Will or consensus between the appointed medical boards and surrogate decision-makers, such as family members or legal guardians.
Clinical and Public Health Implications
From a public health perspective, establishing clear protocols for end-of-life care addresses several longstanding challenges in critical care medicine.
“When treatment transitions from beneficial care to technological prolongation of the dying process, it creates significant moral distress for healthcare workers and immense financial strain for families,” notes Dr. Rajesh Kumar, a senior critical care specialist not involved in the state rollout. “Standardizing this mechanism provides legal safety for doctors while ensuring that patient dignity, rather than fear of litigation, guides clinical decisions.”
Key Impacts on Hospitals and Families
-
Reduction of Avoidable ICU Escalation: Clear pathways help prevent non-beneficial, invasive procedures in end-stage terminal conditions, optimizing ICU bed capacity for patients with reversible critical illnesses.
-
Mitigation of Financial Toxicity: Terminal ICU admissions often exhaust family savings on ineffective interventions. A structured protocol allows families to transition away from aggressive, futile care toward palliative comfort care.
-
Enhanced Transparency: Decisions are no longer left to individual doctor discretion, reducing systemic mistrust through multi-specialist audits and written documentation.
Implementation Challenges and Limitations
Despite widespread endorsement from critical care and palliative medicine societies, medical ethicists highlight practical barriers to seamless implementation across all tiers of the health system:
-
Shortage of Specialized Personnel: The protocol requires multiple experienced specialists for both Primary and Secondary boards. While tertiary centers and private multi-specialty hospitals in major cities like Gurgaon can easily assemble these panels, rural district hospitals may struggle to meet the specialist staffing requirements.
-
Palliative Care Deficits: Withdrawing life support must always be paired with active symptom management and end-of-life palliative care. Many secondary-level hospitals currently lack dedicated palliative care teams or access to controlled analgesics required for compassionate end-of-life transitions.
-
Awareness Gaps: Public literacy regarding Advance Directives remains minimal in India. Without proactive community awareness, families during acute health crises may mistake life-support withdrawal for abandonment of care.
What Patients and Families Should Know
Health authorities emphasize that the rollout of these directives does not empower medical teams to unilaterally terminate care.
-
Strict Eligibility: The protocol applies strictly to patients suffering from terminal, irreversible conditions where medical therapy is documented to be non-beneficial.
-
Role of Advance Directives: Adults can draft an Advance Medical Directive detailing their treatment preferences in the event of incapacitation. Living wills must be executed voluntarily in the presence of two independent witnesses and attested by a notary or gazetted officer.
-
Proactive Communication: Families facing chronic or terminal diagnoses are encouraged to hold early, open discussions with treating clinical teams regarding prognosis, care goals, and palliative care options long before an ICU crisis occurs.
References
- https://health.economictimes.indiatimes.com/news/policy/haryana-govt-rolls-out-life-support-withdrawal-guidelines-to-set-up-medical-boards/132657996?utm_source=latest_news&utm_medium=homepage
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
